Your browser is no longer supported. Please, upgrade your browser.
Settings
SPPI Spectrum Pharmaceuticals, Inc. daily Stock Chart
SPPI [NASD]
Spectrum Pharmaceuticals, Inc.
Index- P/E- EPS (ttm)-0.99 Insider Own0.80% Shs Outstand95.55M Perf Week2.92%
Market Cap1.38B Forward P/E- EPS next Y-0.68 Insider Trans0.00% Shs Float85.86M Perf Month43.17%
Income-78.30M PEG- EPS next Q-0.25 Inst Own61.40% Short Float10.38% Perf Quarter83.97%
Sales132.00M P/S10.47 EPS this Y-20.20% Inst Trans0.03% Short Ratio6.86 Perf Half Y123.15%
Book/sh2.53 P/B5.72 EPS next Y35.80% ROA-18.70% Target Price19.00 Perf Year262.41%
Cash/sh1.45 P/C9.98 EPS next 5Y- ROE-34.70% 52W Range3.21 - 15.32 Perf YTD226.41%
Dividend- P/FCF- EPS past 5Y-25.30% ROI-17.80% 52W High-5.61% Beta1.55
Dividend %- Quick Ratio2.90 Sales past 5Y-5.40% Gross Margin66.10% 52W Low350.47% ATR0.66
Employees227 Current Ratio3.10 Sales Q/Q1.20% Oper. Margin-55.20% RSI (14)70.75 Volatility4.97% 5.82%
OptionableYes Debt/Eq0.50 EPS Q/Q26.50% Profit Margin-59.30% Rel Volume1.33 Prev Close13.94
ShortableYes LT Debt/Eq0.50 EarningsNov 02 AMC Payout- Avg Volume1.30M Price14.46
Recom1.50 SMA2014.05% SMA5033.31% SMA20094.26% Volume1,732,215 Change3.73%
Oct-04-17Reiterated H.C. Wainwright Buy $14 → $20
Aug-16-17Resumed H.C. Wainwright Buy $14
Feb-10-17Resumed Jefferies Buy
Nov-05-15Reiterated RBC Capital Mkts Outperform $13 → $12
Aug-07-15Reiterated RBC Capital Mkts Outperform $12 → $13
Apr-02-15Initiated FBR Capital Outperform $9
Feb-23-15Downgrade ROTH Capital Buy → Neutral $15 → $7
Jul-15-14Upgrade R. F. Lafferty Sell → Neutral $7.50
Oct-07-13Initiated HC Wainwright Buy $15
May-29-13Initiated Burrill Institutional Research Mkt Outperform $12
Mar-13-13Reiterated RBC Capital Mkts Outperform $19 → $16
Mar-13-13Downgrade WallachBeth Buy → Sell $20 → $5.50
May-02-11Reiterated MLV Capital Buy $12.50 → $20.50
Mar-25-11Initiated RBC Capital Mkts Outperform $12
Dec-07-10Reiterated Morgan Joseph Buy $8 → $10
Jan-12-10Upgrade Morgan Joseph Hold → Buy $8
Oct-14-09Reiterated Rodman & Renshaw Mkt Outperform $10 → $8
Sep-08-09Downgrade Morgan Joseph Buy → Hold
Sep-09-08Initiated Morgan Joseph Buy $5
Apr-23-08Downgrade Oppenheimer Outperform → Perform
Oct-10-17 04:30PM  Stonegate Capital Partners Updates Coverage on Spectrum Pharmaceuticals, Inc. (NasdaqGS: SPPI) ACCESSWIRE
07:00AM  Spectrum Pharmaceuticals Announces Agreements to Exchange $69.5 Million in Principal Amount of Its 2.75% Convertible Senior Notes Due 2018 for Common Stock and Cash Business Wire
Oct-09-17 12:02PM  ETFs with exposure to Spectrum Pharmaceuticals, Inc. : October 9, 2017 Capital Cube
Oct-06-17 07:15PM  Top 4 Small-Cap Stocks for 2017 Investopedia
Sep-30-17 10:34AM  3 Biotech Stocks That Soared This Week: Are They Buys? Motley Fool
Sep-29-17 10:38AM  ETFs with exposure to Spectrum Pharmaceuticals, Inc. : September 29, 2017 Capital Cube
08:00AM  Today's Research Reports on Trending Tickers: MannKind Corporation and Spectrum Pharmaceuticals ACCESSWIRE
07:00AM  Spectrum Pharmaceuticals Provides Update on At-The-Market Facility Business Wire
Sep-28-17 01:46PM  Here's Why Spectrum Pharmaceuticals, Inc. Is Surging Today Motley Fool +22.97%
07:00AM  Spectrum Pharmaceuticals Highlights Poziotinib Data in Lung Cancer to be Presented in an Oral Presentation at the 18th IASLC World Conference on Lung Cancer in Yokohama, Japan, October 15-18, 2017 Business Wire
Sep-05-17 07:00AM  Spectrum Pharmaceuticals to Present at Two Upcoming Investor Conferences in September Business Wire
Sep-01-17 10:38AM  Evomelas Market Share Is Increasing in 2017 Market Realist
Aug-25-17 05:34PM  ETFs with exposure to Spectrum Pharmaceuticals, Inc. : August 25, 2017 Capital Cube
Aug-17-17 07:00AM  Spectrum Pharmaceuticals to Present Corporate Update at the 2017 Southern California Investor Conference in Newport Beach on Thursday, August 24th Business Wire
Aug-16-17 05:44PM  Spectrum (SPPI) Initiates Phase II Study for Cancer Drug Zacks
10:28AM  Spectrum Pharmaceuticals, Inc. :SPPI-US: Earnings Analysis: Q2, 2017 By the Numbers : August 16, 2017 Capital Cube
Aug-14-17 07:00AM  Spectrum Pharmaceuticals Announces Initiation of the Registrational Phase 3 Trial of Qapzola (apaziquone) in Patients with Non-Muscle Invasive Bladder Cancer (NMIBC) Business Wire
Aug-11-17 11:20PM  Edited Transcript of SPPI earnings conference call or presentation 3-Aug-17 8:30pm GMT Thomson Reuters StreetEvents +5.49%
Aug-08-17 11:14AM  Ligand (LGND) Q2 Earnings & Revenues Top, 2017 View Raised Zacks
Aug-07-17 08:20AM  Spectrum Pharmaceuticals (SPPI) Looks Good: Stock Jumps 22.2% Zacks
08:10AM  Today's Research Reports on Stocks to Watch: Cara Therapeutics, Inc. and Spectrum Pharmaceuticals ACCESSWIRE
Aug-04-17 02:10PM  Why Spectrum Pharmaceuticals Stock Is Bolting Higher Today Motley Fool +22.24%
10:07AM  Spectrum (SPPI) Q2 Loss Narrower than Expected, Sales Beat Zacks
Aug-03-17 04:02PM  Spectrum Pharmaceuticals Reports Second Quarter 2017 Financial Results and Pipeline Update Business Wire
12:30PM  Investor Network: Spectrum Pharmaceuticals, Inc. to Host Earnings Call ACCESSWIRE
Aug-01-17 07:00AM  Spectrum Pharmaceuticals Announces Completion of Enrollment in the Phase 3 Pivotal Study (ADVANCE) of ROLONTIS (eflapegrastim), a Novel Long-Acting GCSF Business Wire
Jul-27-17 07:00AM  Spectrum Pharmaceuticals Announces Second Quarter 2017 Financial Results Teleconference and Webcast Business Wire -6.48%
Jun-19-17 07:00AM  Spectrum Pharmaceuticals Highlights Results of a Combination Study of FOLOTYN® (pralatrexate injection) Plus Romidepsin Presented at the 14th International Conference on Malignant Lymphoma (14-ICML) Meeting Business Wire
Jun-12-17 02:57PM  Spectrum Pharmaceuticals, Inc. Value Analysis (NASDAQ:SPPI) : June 12, 2017 Capital Cube
Jun-09-17 08:35AM  Spectrum Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : SPPI-US : June 9, 2017 Capital Cube
Jun-02-17 07:00AM  Spectrum Pharmaceuticals Highlights Three Abstracts of Clinical Data at the 2017 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Illinois, June 2-6, 2017 Business Wire
May-30-17 07:00AM  Spectrum Pharmaceuticals to Present Corporate Update at the Jefferies 2017 Global Healthcare Conference on June 6th Business Wire
May-19-17 03:11PM  Edited Transcript of SPPI earnings conference call or presentation 2-May-17 8:30pm GMT Thomson Reuters StreetEvents
May-16-17 07:00AM  Spectrum Pharmaceuticals to Present Corporate Update at the Bank of America Merrill Lynch 2017 Health Care Conference on May 17 Business Wire
May-08-17 05:15PM  ETFs with exposure to Spectrum Pharmaceuticals, Inc. : May 8, 2017 Capital Cube
May-05-17 10:29AM  Spectrum Pharmaceuticals, Inc. :SPPI-US: Earnings Analysis: Q1, 2017 By the Numbers : May 5, 2017 Capital Cube
08:55AM  Spectrum Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : SPPI-US : May 5, 2017 Capital Cube
May-04-17 01:36PM  Edited Transcript of SPPI earnings conference call or presentation 2-May-17 8:30pm GMT Thomson Reuters StreetEvents
May-03-17 01:04PM  Why Spectrum Pharmaceuticals Stock Is Sinking Today Motley Fool -11.55%
10:09AM  Biotech Movers: Myriad Genetics, Spectrum Pharmaceuticals, Array BioPharma TheStreet.com
May-02-17 06:06PM  Spectrum Pharma reports 1Q loss Associated Press
04:02PM  Spectrum Pharmaceuticals Reports First Quarter 2017 Financial Results and Pipeline Update Business Wire
Apr-27-17 04:17PM  ETFs with exposure to Spectrum Pharmaceuticals, Inc. : April 27, 2017 Capital Cube
07:00AM  Spectrum Pharmaceuticals to Present Corporate Update at the 42nd Annual Deutsche Bank Health Care Conference on May 4 Business Wire
Apr-25-17 07:00AM  Spectrum Pharmaceuticals Announces First Quarter 2017 Financial Results Teleconference and Webcast Business Wire
Apr-21-17 07:30AM  Today's Research Reports on Biotech Stocks to Watch: Celldex Therapeutics and Spectrum Pharmaceuticals Accesswire
Apr-14-17 08:04AM  Spectrum Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : SPPI-US : April 14, 2017 Capital Cube
Apr-07-17 05:30PM  ETFs with exposure to Spectrum Pharmaceuticals, Inc. : April 7, 2017 Capital Cube
Apr-04-17 07:00AM  Spectrum Pharmaceuticals Highlights Preclinical Data of ROLONTIS (eflapegrastim) at the American Association for Cancer Research (AACR) Annual Meeting Business Wire
07:00AM  Spectrum Pharmaceuticals Highlights Preclinical Data of ROLONTIS (eflapegrastim) at the American Association for Cancer Research (AACR) Annual Meeting
Mar-31-17 09:09AM  Spectrum (SPPI) Initiates Phase II Study for Cancer Candidate Zacks
09:09AM  Spectrum (SPPI) Initiates Phase II Study for Cancer Candidate
07:00AM  Spectrum Pharmaceuticals Highlights Three Abstracts on ROLONTIS (eflapegrastim) and BELEODAQ® (belinostat) for injection at the American Association for Cancer Research (AACR) Annual Meeting in Washington, D.C., April 1-5, 2017 Business Wire
07:00AM  Spectrum Pharmaceuticals Highlights Three Abstracts on ROLONTIS (eflapegrastim) and BELEODAQ® (belinostat) for injection at the American Association for Cancer Research (AACR) Annual Meeting in Washington, D.C., April 1-5, 2017
Mar-30-17 07:00AM  Spectrum Pharmaceuticals Announces Initiation of a Phase 2 Trial of Poziotinib in Non-Small Cell Lung Cancer Patients with EGFR Exon 20 Insertion Mutations Business Wire
Mar-18-17 01:04PM  SPECTRUM PHARMACEUTICALS INC Financials
Mar-14-17 05:32PM  SPECTRUM PHARMACEUTICALS INC Files SEC form 10-K, Annual Report
Mar-10-17 04:06PM  SPECTRUM PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers +5.12%
Mar-09-17 10:58AM  Spectrum Pharmaceuticals, Inc. :SPPI-US: Earnings Analysis: Q4, 2016 By the Numbers : March 9, 2017 Capital Cube
10:58AM  Spectrum Pharmaceuticals, Inc. :SPPI-US: Earnings Analysis: Q4, 2016 By the Numbers : March 9, 2017
10:07AM  Biotech Premarket Movers: Spectrum, BioCryst, Curis TheStreet.com
10:07AM  Biotech Premarket Movers: Spectrum, BioCryst, Curis
09:15AM  Spectrum (SPPI) Q4 Loss Narrower than Expected, Sales Beat Zacks
09:15AM  Spectrum (SPPI) Q4 Loss Narrower than Expected, Sales Beat
Mar-08-17 04:32PM  Spectrum Pharma reports 4Q loss Associated Press
04:32PM  Spectrum Pharma reports 4Q loss
04:06PM  SPECTRUM PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements
04:02PM  Spectrum Pharmaceuticals Reports Fourth Quarter 2016 and Full Year 2016 Financial Results and Pipeline Update Business Wire
07:07AM  Q4 2016 Spectrum Pharmaceuticals Inc Earnings Release - After Market Close
Mar-06-17 06:34PM  Can Epizyme (EPZM) Spring a Surprise This Earnings Season?
06:32PM  AVEO Pharmaceuticals (AVEO) Q4 Earnings: What's in Store?
10:06AM  Semtech (SMTC) to Report Q4 Earnings: Will it Disappoint?
08:50AM  Should You Buy Spectrum Pharmaceuticals (SPPI) Ahead of Earnings?
Mar-01-17 07:00AM  Spectrum Pharmaceuticals Announces Fourth Quarter and Full Year 2016 Financial Results Teleconference and Webcast Business Wire +5.16%
Feb-27-17 11:20AM  Spectrum Pharma Sued Again For 'Misleading Investors at Investopedia +8.02%
Feb-16-17 07:00AM  Spectrum Pharmaceuticals to Present Corporate Update at the 2017 RBC Capital Markets Global Healthcare Conference on February 23rd Business Wire
Jan-20-17 02:03PM  ETFs with exposure to Spectrum Pharmaceuticals, Inc. : January 20, 2017
Jan-09-17 06:02AM  SPECTRUM PHARMACEUTICALS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
Dec-20-16 02:31PM  Is Steel Partners Holdings LP (SPLP) A Good Stock To Buy According To Other Hedge Funds? at Insider Monkey
Dec-14-16 01:35PM  ETFs with exposure to Spectrum Pharmaceuticals, Inc. : December 14, 2016
Dec-12-16 09:48AM  Should You Avoid Spectrum Pharmaceuticals, Inc. (SPPI)? at Insider Monkey
Dec-09-16 05:11AM  These small-cap stocks are expected to rise at least 31% in 2017 at MarketWatch +6.73%
Dec-08-16 07:00AM  Spectrum Pharmaceuticals Highlights Promising Preclinical Data Evaluating Poziotinib in Lung Cancer at the 17th IASLC World Conference on Lung Cancer Business Wire
Dec-06-16 07:00AM  Spectrum Pharmaceuticals Highlights Survival Advantage in a Case Match Control Analysis of the PROPEL Study with FOLOTYN® (pralatrexate injection) at the 58th Annual Meeting of the American Society of Hematology (ASH) Business Wire
Dec-05-16 01:05PM  10 Major Pharma and FDA Catalysts Coming in December at 24/7 Wall St.
07:00AM  Spectrum Pharmaceuticals Highlights Five Abstracts on ROLONTIS (eflapegrastim) and Poziotinib at the San Antonio Breast Cancer Symposium (SABCS) in San Antonio, Texas, December 6-10, 2016 Business Wire
Dec-02-16 07:00AM  Spectrum Pharmaceuticals Highlights Four Abstracts at the 58th Annual Meeting of the American Society of Hematology (ASH) in San Diego, California, December 3-6, 2016 Business Wire
Nov-29-16 03:15PM  SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Spectrum Pharmaceuticals, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors Accesswire
07:24AM  Spectrum Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : SPPI-US : November 29, 2016
Nov-28-16 12:30PM  ETFs with exposure to Spectrum Pharmaceuticals, Inc. : November 28, 2016 -5.31%
Nov-23-16 06:31AM  Biotech Stock Roundup: Acorda Stops Ampyra PSWD Development, CRL for Spectrum's Qapzola
Nov-22-16 11:14AM  Spectrum Pharmaceuticals, Inc. :SPPI-US: Earnings Analysis: Q3, 2016 By the Numbers : November 22, 2016
Nov-21-16 08:55AM  Spectrum Bladder Cancer Drug Nixed by FDA (SPPI) at Investopedia +5.85%
07:24AM  Spectrum (SPPI) Gets CRL for Bladder Cancer Drug in U.S.
Nov-18-16 12:06PM  3-DAY DEADLINE: Khang & Khang LLP Announces Securities Class Action Lawsuit against Spectrum Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm Accesswire
11:04AM  SPPI UPCOMING DEADLINE: The Law Offices of Vincent Wong Reminds Shareholders of a Class Action Involving Spectrum Pharmaceuticals, Inc. and a Lead Plaintiff Deadline of November 21, 2016 PR Newswire
06:22AM  Spectrum Pharma says U.S. FDA rejects its bladder cancer drug Reuters
06:01AM  SPECTRUM PHARMACEUTICALS INC Files SEC form 8-K, Other Events
Nov-17-16 11:47AM  UPCOMING DEADLINE: Lundin Law PC Announces Securities Class Action Lawsuit against Spectrum Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm Accesswire
10:30AM  Deadline Alert: Law Offices of Howard G. Smith Reminds Investors of the Upcoming November 21st Deadline in the Class Action Lawsuit Against Spectrum Pharmaceuticals, Inc. Business Wire
Spectrum Pharmaceuticals, Inc. develops and commercializes oncology and hematology drug products. The company markets six drug products, including FUSILEV for patients with metastatic colorectal cancer and rescue after high-dose methotrexate therapy in osteosarcoma, and to diminish toxicity and counteract the effects of impaired methotrexate elimination and of inadvertent overdosage of folic acid antagonists; FOLOTYN, a folate analogue metabolic inhibitor to treat patients with relapsed or refractory PTCL; ZEVALIN injection for patients with follicular non-Hodgkin's lymphoma; MARQIBO, a sphingomyelin/cholesterol liposome-encapsulated formulation for adult patients with Philadelphia chromosome-negative acute lymphoblastic leukemia; BELEODAQ injection for patients with relapsed or refractory PTCL; and EVOMELA for use as a conditioning treatment prior to autologous stem cell transplant in multiple myeloma patients. It is also developing ROLONTIS for chemotherapy-induced neutropenia; QAPZOLA for intravesical instillation in post-transurethral resection of bladder tumors in patients with non-muscle invasive bladder cancer; and POZIOTINIB for treating breast and lung cancer. The company sells its drugs through a direct sales force in the United States; and through distributors in Europe. Spectrum Pharmaceuticals, Inc. has licensing and development agreement with Cell Therapeutics, Inc.; license agreement with Merck & Cie AG, Sloan-Kettering Institute, and Cydex Pharmaceuticals, Inc.; development and commercialization collaboration agreement with Allergan, Inc.; collaboration agreement with Nippon Kayaku Co., LTD.; licensing and collaboration agreement with Onxeo DK; and co-development and commercialization agreement with Hanmi Pharmaceutical Company. The company was formerly known as NeoTherapeutics, Inc. and changed its name to Spectrum Pharmaceuticals, Inc. in December 2002. Spectrum Pharmaceuticals, Inc. was founded in 1987 and is headquartered in Henderson, Nevada.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
MAIDA ANTHONY E IIIDirectorJul 17Option Exercise6.9015,000103,50037,175Jul 18 06:02 PM
Krassner Stuart MitchellDirectorJul 17Option Exercise6.9015,000103,50067,444Jul 18 06:00 PM